Kring S, Spindler K
J Virol. 1996; 70(8):5495-502.
PMID: 8764061
PMC: 190507.
DOI: 10.1128/JVI.70.8.5495-5502.1996.
Lopes M, DosReis G
Infect Immun. 1996; 64(5):1559-64.
PMID: 8613360
PMC: 173961.
DOI: 10.1128/iai.64.5.1559-1564.1996.
Cardillo F, Voltarelli J, Reed S, Silva J
Infect Immun. 1996; 64(1):128-34.
PMID: 8557330
PMC: 173737.
DOI: 10.1128/iai.64.1.128-134.1996.
Sciutto E, Fragoso G, Baca M, de la Cruz V, Lemus L, Lamoyi E
Infect Immun. 1995; 63(6):2277-81.
PMID: 7768609
PMC: 173297.
DOI: 10.1128/iai.63.6.2277-2281.1995.
Choromanski L, Kuhn R
Infect Immun. 1985; 50(2):354-7.
PMID: 3932205
PMC: 261956.
DOI: 10.1128/iai.50.2.354-357.1985.
Suppressor factor of T-cell activation and decreased interleukin 2 activity in experimental African trypanosomiasis.
Alcina A, Fresno M
Infect Immun. 1985; 50(2):382-7.
PMID: 3876993
PMC: 261961.
DOI: 10.1128/iai.50.2.382-387.1985.
Tumour necrosis factor (cachectin) production during experimental Chagas' disease.
Tarleton R
Clin Exp Immunol. 1988; 73(2):186-90.
PMID: 3141092
PMC: 1541603.
Suppression of human lymphocyte responses by Trypanosoma cruzi.
Beltz L, Kierszenbaum F
Immunology. 1987; 60(2):309-15.
PMID: 3102355
PMC: 1453223.
Deficiency of interleukin-2 activity upon addition of soluble egg antigen to cultures of spleen cells from mice infected with Schistosoma japonicum.
Stavitsky A, Harold W
Infect Immun. 1988; 56(7):1778-84.
PMID: 2968321
PMC: 259477.
DOI: 10.1128/iai.56.7.1778-1784.1988.
Use of parasite antigens and interleukin-2 to enhance suppressed immune responses during Trypanosoma cruzi infection in mice.
Choromanski L, Kuhn R
Infect Immun. 1987; 55(2):403-8.
PMID: 2948917
PMC: 260341.
DOI: 10.1128/iai.55.2.403-408.1987.
Immunological and nonimmunological control of severity of Trypanosoma musculi infections in C3H and C57BL/6 inbred mice.
Albright J, Albright J
Infect Immun. 1989; 57(6):1647-55.
PMID: 2785960
PMC: 313334.
DOI: 10.1128/iai.57.6.1647-1655.1989.
Selective suppressive effects of Trypanosoma cruzi on activated human lymphocytes.
Beltz L, Kierszenbaum F, Sztein M
Infect Immun. 1989; 57(8):2301-5.
PMID: 2663720
PMC: 313446.
DOI: 10.1128/iai.57.8.2301-2305.1989.
Deficiency of interleukin-2 production upon addition of soluble egg antigen to cultures of isolated hepatic granulomas or hepatic granuloma cells from mice infected with Schistosoma japonicum.
Stavitsky A, Harold W
Infect Immun. 1989; 57(8):2339-44.
PMID: 2526099
PMC: 313452.
DOI: 10.1128/iai.57.8.2339-2344.1989.
Elevated environmental temperature enhances immunity in experimental Chagas' disease.
Anderson K, Kuhn R
Infect Immun. 1989; 57(1):13-7.
PMID: 2491831
PMC: 313033.
DOI: 10.1128/iai.57.1.13-17.1989.
Repeated antigenic stimulation overcomes immunosuppression in experimental Chagas' disease.
Choromanski L, Kuhn R
Immunology. 1986; 59(2):289-94.
PMID: 2429922
PMC: 1453176.
Genomic variation of Trypanosoma cruzi: involvement of multicopy genes.
Wagner W, So M
Infect Immun. 1990; 58(10):3217-24.
PMID: 2169461
PMC: 313642.
DOI: 10.1128/iai.58.10.3217-3224.1990.
Effect of elevated environmental temperature on the antibody response of mice to Trypanosoma cruzi during the acute phase of infection.
Dimock K, DAVIS C, Kuhn R
Infect Immun. 1991; 59(12):4377-82.
PMID: 1937796
PMC: 259052.
DOI: 10.1128/iai.59.12.4377-4382.1991.
Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta).
Silva J, Twardzik D, Reed S
J Exp Med. 1991; 174(3):539-45.
PMID: 1908509
PMC: 2118925.
DOI: 10.1084/jem.174.3.539.
Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection.
Silva J, Morrissey P, Grabstein K, Mohler K, Anderson D, Reed S
J Exp Med. 1992; 175(1):169-74.
PMID: 1730915
PMC: 2119081.
DOI: 10.1084/jem.175.1.169.
Antigen-specific T-helper cells abrogate suppression in Trypanosoma cruzi-infected mice.
Ritter D, Kuhn R
Infect Immun. 1990; 58(10):3248-56.
PMID: 1698177
PMC: 313646.
DOI: 10.1128/iai.58.10.3248-3256.1990.